Arcus Biosciences Inc
(RCUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | |
| Cash Flows From Operating Activities | |
| Net Income | -17,970 |
| Depreciation Amortization | 1,314 |
| Other Working Capital | 3,622 |
| Other Operating Activity | 90 |
| Operating Cash Flow | $-12,944 |
| Cash Flows From Investing Activities | |
| PPE Investments | -4,099 |
| Other Investing Activity | -34,762 |
| Investing Cash Flow | $-38,861 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 70,100 |
| Financing Cash Flow | $70,100 |
| Beginning Cash Position | 46,865 |
| End Cash Position | 65,160 |
| Net Cash Flow | $18,295 |
| Free Cash Flow | |
| Operating Cash Flow | -12,944 |
| Free Cash Flow | -12,944 |